ATGE · Insider Trading
Adtalem Global Education Inc. Common Shares
Every open-market purchase and sale reported by ATGE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-12 | Stephen W. Beard | Chairman & CEO | G | −5,332 | — |
| 2025-11-14 | Evan Trent | President, Adtalem Elevate | MIXED | +1,318 | +$127.87K |
| 2025-11-14 | Sharon O'Keefe | Director | A | +1,445 | +$139.96K |
| 2025-11-14 | Megan Noel | Chief Corp. Affairs Officer | A | +2,226 | +$215.61K |
| 2025-11-14 | Georgette D. Kiser | Director | MIXED | +1,020 | +$99.05K |
| 2025-11-14 | Sara Hill | CHRO | A | +1,673 | +$162.05K |
| 2025-11-14 | Karen Sue Cox | President, Chamberlain Univ. | MIXED | +271 | +$26.44K |
| 2025-11-14 | Michael W Malafronte | Director | MIXED | +919 | +$89.33K |
| 2025-11-14 | Maurice Herrera | SVP - Chief Marketing Officer | MIXED | +1,407 | +$136.49K |
| 2025-11-14 | William W Burke | Director | MIXED | +1,055 | +$102.42K |
| 2025-11-14 | Michael Betz | Pres. Walden University & CDO | MIXED | +5,134 | +$497.54K |
| 2025-11-14 | Kenneth J Phelan | Director | MIXED | +1,053 | +$102.23K |
| 2025-11-14 | Donna J Hrinak | Director | MIXED | +1,101 | +$106.85K |
| 2025-11-14 | Betty M. Vandenbosch | Director | MIXED | +1,024 | +$99.44K |
| 2025-11-14 | Stephen W. Beard | Chairman & CEO | F | −9,204 | −$885.98K |
| 2025-11-14 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | MIXED | +1,714 | +$166.23K |
| 2025-11-14 | Lisa W Wardell | Director | MIXED | +800 | +$77.88K |
| 2025-11-14 | Robert J. Phelan | Chief Financial Officer | MIXED | +3,636 | +$352.56K |
| 2025-11-14 | Manjunath Gangadharan | VP, Chief Accounting Officer | MIXED | +796 | +$77.16K |
| 2025-11-14 | Scott Liles | President, Medical and Vet | MIXED | +2,206 | +$213.92K |
| 2025-11-14 | William V Krehbiel | Director | MIXED | +1,024 | +$99.44K |
| 2025-11-12 | Robert J. Phelan | Chief Financial Officer | F | −1,637 | −$155.83K |
| 2025-11-05 | Kenneth J Phelan | Director | Buy | +508 | +$49.93K |
| 2025-11-04 | Michael W Malafronte | Director | Buy | +1,000 | +$91.85K |
| 2025-10-16 | Sara Hill | CHRO | F | −1,310 | −$194.69K |
| 2025-09-09 | Stephen W. Beard | Chairman & CEO | F | −12,943 | −$1.76M |
| 2025-08-29 | Lisa W Wardell | Director | Sell | −25,477 | −$3.37M |
| 2025-08-27 | Robert J. Phelan | Chief Financial Officer | MIXED | +19,904 | +$2.68M |
| 2025-08-27 | Stephen W. Beard | Chairman & CEO | MIXED | +132,781 | +$17.91M |
| 2025-08-27 | Sara Hill | CHRO | MIXED | +1,223 | +$164.96K |
| 2025-08-27 | Manjunath Gangadharan | VP, Chief Accounting Officer | MIXED | +601 | +$80.32K |
| 2025-08-27 | Lisa W Wardell | Director | MIXED | −23,549 | −$3.18M |
| 2025-08-27 | Michael Betz | Pres. Walden University & CDO | MIXED | +11,271 | +$1.52M |
| 2025-08-27 | Maurice Herrera | SVP - Chief Marketing Officer | MIXED | +7,438 | +$1.00M |
| 2025-08-27 | Evan Trent | President, Adtalem Elevate | MIXED | +8,367 | +$1.13M |
| 2025-08-27 | Karen Sue Cox | President, Chamberlain Univ. | MIXED | +9,280 | +$1.25M |
| 2025-08-27 | Scott Liles | President, Medical and Vet | MIXED | +4,060 | +$547.61K |
| 2025-08-27 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | MIXED | +8,936 | +$1.21M |
| 2025-08-25 | Lisa W Wardell | Director | Sell | −12,900 | −$1.71M |
| 2025-06-16 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | F | −3,513 | −$428.02K |
| 2025-06-06 | William W Burke | Director | Sell | −2,291 | −$294.05K |
| 2025-05-22 | Manjunath Gangadharan | VP, Chief Accounting Officer | Sell | −966 | −$127.18K |
| 2025-05-20 | Manjunath Gangadharan | VP, Chief Accounting Officer | F | −414 | −$55.78K |
| 2025-04-16 | Scott Liles | President, Medical and Vet | F | −458 | −$48.71K |
| 2025-03-07 | Michael W Malafronte | Director | Buy | +1,000 | +$87.21K |
| 2025-02-24 | Donna J Hrinak | Director | Sell | −915 | −$89.60K |
| 2025-02-18 | Donna J Hrinak | Director | Sell | −4,812 | −$496.87K |
| 2025-02-10 | Donna J Hrinak | Director | Sell | −4,685 | −$509.16K |
| 2025-02-07 | Michael Betz | Pres. Walden University & CDO | Sell | −3,500 | −$379.99K |
| 2024-12-17 | Michael W Malafronte | Director | G | −5,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Stephen W. Beard | Chairman & CEO | 445,198 | $43.87M |
| Michael W Malafronte | Director | 101,890 | $10.04M |
| Robert J. Phelan | Chief Financial Officer | 66,429 | $6.55M |
| Douglas G. Beck | SVP, GC, Corp. Sec & ISS | 48,135 | $4.74M |
| Lisa W Wardell | Director | 44,251 | $4.36M |
| Karen Sue Cox | President, Chamberlain Univ. | 33,596 | $3.31M |
| Michael Betz | Pres. Walden University & CDO | 33,286 | $3.28M |
| Evan Trent | President, Adtalem Elevate | 24,134 | $2.38M |
| Maurice Herrera | SVP - Chief Marketing Officer | 20,927 | $2.06M |
| Kenneth J Phelan | Director | 20,228 | $1.99M |
| Georgette D. Kiser | Director | 17,481 | $1.72M |
| William V Krehbiel | Director | 16,724 | $1.65M |
| Sharon O'Keefe | Director | 16,597 | $1.64M |
| Scott Liles | President, Medical and Vet | 13,551 | $1.34M |
| Steven Tom | SVP Chief Customer Officer | 13,255 | $1.31M |
| William W Burke | Director | 10,423 | $1.03M |
| Sara Hill | CHRO | 10,276 | $1.01M |
| Blake Simpson | SVP, Chief Comms & CA Officer | 8,795 | $866.66K |
| Donna J Hrinak | Director | 8,218 | $809.80K |
| Mayur Gupta | Director | 6,667 | $656.97K |
| Manjunath Gangadharan | VP, Chief Accounting Officer | 5,697 | $561.38K |
| Betty M. Vandenbosch | Director | 3,005 | $296.11K |
| Megan Noel | Chief Corp. Affairs Officer | 2,226 | $219.35K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ATGE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.